BIM
ACHV icon

Bogle Investment Management’s Achieve Life Sciences ACHV Stock Holding History

Bogle Investment Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-40
Closed -$187K – 342
2015
Q1 		$187K Hold
40
– – 0.01% 333
2014
Q4 		$200K Sell
40
-6
-13% -$29.3K 0.01% 330
2014
Q3 		$267K Sell
46
-34
-43% -$236K 0.02% 314
2014
Q2 		$656K Sell
80
-16
-17% -$197K 0.04% 261
2014
Q1 		$2.48M Buy
+96
New +$2.36M 0.17% 173

Other funds holding ACHV

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Bogle Investment Management's ACHV Position: Q2 2015 in Review

Bogle Investment Management sold out of Achieve Life Sciences (ACHV) in Q2 2015, closing a stake of 40 shares — an estimated $187K sold.

Bogle Investment Management first reported a position in ACHV in Q1 2014 and held it in 5 quarters. The position peaked at $2.48M in Q1 2014. 48 funds tracked by Wall St. Rank hold ACHV as of Q2 2015.

  • Bogle Investment Management reported no remaining Achieve Life Sciences position as of Q2 2015 after selling out during the quarter.
  • Bogle Investment Management sold 40 Achieve Life Sciences shares in Q2 2015, an estimated $187K.
  • Bogle Investment Management first reported a position in Achieve Life Sciences in Q1 2014 and held it in 5 quarters.
  • Bogle Investment Management's Achieve Life Sciences position peaked at $2.48M in Q1 2014.
  • 48 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2015.

Based on Bogle Investment Management's 13F filing for Q2 2015, filed 13 Aug 2015.